Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The spectrum ranges from simple steatosis (fat accumulation without significant inflammation) to nonalcoholic steatohepatitis (NASH), which involves inflammation and hepatocyte injury that can progress to fibrosis, cirrhosis, and hepatocellular carcinoma
Treating obesity in silo with a product and not addressing whole health results in short-lived results with continued risks and complications of comorbidities
Some patients and clinicians explore whether GLP-1 medications can be used as a "bridge" to establish healthier habits, with the hope of discontinuing therapy once weight loss goals are achieved and lifestyle modifications are firmly established
10.1164/rccm.200212-1479SO
US$ 23.88
US$ 24.35
US$ 24.59
US$ 25.13
US$ 28.57
